{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:07:46Z","timestamp":1783580866023,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.pupt.2023.102246","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T22:20:29Z","timestamp":1691533229000},"page":"102246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers"],"prefix":"10.1016","volume":"82","author":[{"given":"Christina","family":"Gress","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Vogel-Claussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Badorrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilisa","family":"Konietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Litzenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-6186","authenticated-orcid":false,"given":"Jens M.","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2023.102246_bib1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2023 Report). Available at https:\/\/goldcopd.org\/2022-gold-reports\/."},{"key":"10.1016\/j.pupt.2023.102246_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1164\/rccm.202102-0253UP","article-title":"Update in chronic obstructive pulmonary disease 2020","volume":"204","author":"Ritchie","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12971-017-0130-2","article-title":"Experimental animal models for COPD: a methodological review","volume":"15","author":"Ghorani","year":"2017","journal-title":"Tob. Induc. Dis."},{"key":"10.1016\/j.pupt.2023.102246_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091416","article-title":"Respiratory viral and bacterial exacerbations of COPD-the role of the airway epithelium","volume":"11","author":"Love","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pupt.2023.102246_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/07853890.2020.1831050","article-title":"Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease","volume":"53","author":"D'Anna","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.pupt.2023.102246_bib6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.pupt.2008.02.002","article-title":"Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: a randomized placebo-controlled trial","volume":"21","author":"Hohlfeld","year":"2008","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2023.102246_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bcp.12546","article-title":"Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease","volume":"79","author":"Gupta","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102246_bib8","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1074\/jbc.M007396200","article-title":"The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains","volume":"276","author":"Leeb-Lundberg","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pupt.2023.102246_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033864","article-title":"Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats","volume":"7","author":"Pouliot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2023.102246_bib10","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.1007\/s11033-022-07539-2","article-title":"A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases","volume":"49","author":"Rex","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.pupt.2023.102246_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23213","article-title":"Bradykinin\/bradykinin 1 receptor promotes brain microvascular endothelial cell permeability and proinflammatory cytokine release by downregulating Wnt3a","volume":"36","author":"Huang","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.pupt.2023.102246_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/rheumatology\/keu015","article-title":"A role for bradykinin in the development of anti-collagen antibody-induced arthritis","volume":"53","author":"Xie","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.pupt.2023.102246_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thoraxjnl-2012-202741","article-title":"Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD","volume":"68","author":"Ricciardolo","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2023.102246_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.1205744","article-title":"Activation of kinin B1 receptors induces chemotaxis of human neutrophils","volume":"80","author":"Ehrenfeld","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pupt.2023.102246_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2005.12.071","article-title":"Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease","volume":"533","author":"Abraham","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102246_bib16","first-page":"176","article-title":"Bradykinin-induced bronchoconstriction in humans. Mode of action","volume":"135","author":"Fuller","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.pupt.2023.102246_bib17","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1097\/CCM.0000000000001268","article-title":"Kinin B1 receptor antagonist BI113823 reduces acute lung injury","volume":"43","author":"Nasseri","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.phrs.2015.12.017","article-title":"Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice","volume":"104","author":"Gurusamy","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pupt.2023.102246_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/jiv426","article-title":"Kinin B1 receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis","volume":"213","author":"Murugesan","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pupt.2023.102246_bib20","first-page":"589","volume":"vol. 3","author":"Gross","year":"2016"},{"key":"10.1016\/j.pupt.2023.102246_bib21","series-title":"A102. COPD: THERAPY","article-title":"Safety and tolerability of four weeks' treatment with a bradykinin 1 receptor antagonist (BI 1026706) in patients with COPD (GOLD I-iii)","author":"Kirsten","year":"2019"},{"key":"10.1016\/j.pupt.2023.102246_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1617-9625-10-13","article-title":"Microbiological components in mainstream and sidestream cigarette smoke","volume":"10","author":"Larsson","year":"2012","journal-title":"Tob. Induc. Dis."},{"key":"10.1016\/j.pupt.2023.102246_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1378\/chest.115.3.829","article-title":"Bacterial endotoxin is an active component of cigarette smoke","volume":"115","author":"Hasday","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2023.102246_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jaci.2012.05.026","article-title":"Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers","volume":"130","author":"Hernandez","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2023.102246_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jamp.2013.1089","article-title":"Effect of inhaled endotoxin on mucociliary clearance and airway inflammation in mild smokers and nonsmokers","volume":"27","author":"Bennett","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.pupt.2023.102246_bib26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00228-015-1920-1","article-title":"Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects","volume":"71","author":"Singh","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102246_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1465-9921-14-137","article-title":"Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist","volume":"14","author":"Leaker","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2023.102246_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101977","article-title":"Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge","volume":"64","author":"Mole","year":"2020","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2023.102246_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01298-2019","article-title":"Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation","volume":"56","author":"Brooks","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2023.102246_bib30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1164\/ajrccm.163.7.2009111","article-title":"Local inflammatory responses following bronchial endotoxin instillation in humans","volume":"163","author":"O'Grady","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046207","article-title":"Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum","volume":"7","author":"R\u00f6pcke","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2023.102246_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0091-6749(91)90189-U","article-title":"Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases","volume":"88","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2023.102246_bib33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/thoraxjnl-2011-201052","article-title":"Summary of the British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults","volume":"66","author":"Du Rand","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2023.102246_bib34","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1164\/rccm.200301-104OC","article-title":"Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma","volume":"169","author":"Erpenbeck","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib35","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1164\/rccm.200403-423OC","article-title":"Metal-rich ambient particles (particulate matter 2.5) cause airway inflammation in healthy subjects","volume":"170","author":"Schaumann","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201310-1825OC","article-title":"Quantification of pulmonary inflammation after segmental allergen challenge using turbo-inversion recovery-magnitude magnetic resonance imaging","volume":"189","author":"Vogel-Claussen","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/tvst.9.4.25","article-title":"Bradykinin 1 receptor antagonist BI1026706 does not reduce central retinal thickness in center-involved diabetic macular edema","volume":"9","author":"Lang","year":"2020","journal-title":"Translat. Vis. Sci.Technol."},{"key":"10.1016\/j.pupt.2023.102246_bib38","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.peptides.2011.05.005","article-title":"Cigarette smoke-induced kinin B1 receptor promotes NADPH oxidase activity in cultured human alveolar epithelial cells","volume":"32","author":"Talbot","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.pupt.2023.102246_bib39","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.peptides.2010.07.008","article-title":"Mechanism of cigarette smoke-induced kinin B(1) receptor expression in rat airways","volume":"31","author":"Lin","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.pupt.2023.102246_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2466-13-19","article-title":"Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development","volume":"13","author":"Janssen","year":"2013","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.pupt.2023.102246_bib41","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1164\/rccm.200706-870OC","article-title":"Endotoxin augments myeloid dendritic cell influx into the airways in patients with allergic asthma","volume":"177","author":"Schaumann","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/jmri.27000","article-title":"Noninvasive monitoring of the response of human lungs to low-dose lipopolysaccharide inhalation challenge using MRI: a feasibility study","volume":"51","author":"Kern","year":"2020","journal-title":"J. Magn. Reson. Imag. : JMRI"},{"key":"10.1016\/j.pupt.2023.102246_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2010.08.008","article-title":"Effect of interferon-\u03b3 on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells","volume":"647","author":"Koumbadinga","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102246_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14728222.2018.1409724","article-title":"Kinin B1 receptors as a therapeutic target for inflammation","volume":"22","author":"Qadri","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pupt.2023.102246_bib45","unstructured":"Krug N, Larbig M, Bonner J, Mueller M, Erpenbeck VJ, Schaumann F, Lloyd P, Hohlfeld JM, Pascoe S. Anti-MCP-1-monoclonal Antibody (ABN912) Attenuates LPS-Induced Monocyte Recruitment into the Lung in Patients with COPD [abstract]."},{"key":"10.1016\/j.pupt.2023.102246_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2014.07.039","article-title":"IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers","volume":"135","author":"Hernandez","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2023.102246_bib47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2147\/COPD.S150576","article-title":"The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial","volume":"13","author":"Patel","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2023.102246_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2050-6511-15-60","article-title":"Anti-TNF inhibits the airways neutrophilic inflammation induced by inhaled endotoxin in human","volume":"15","author":"Michel","year":"2014","journal-title":"BMC Pharmacol.Toxicol."},{"key":"10.1016\/j.pupt.2023.102246_bib49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1164\/ajrccm.156.4.97-02002","article-title":"Dose-response relationship to inhaled endotoxin in normal subjects","volume":"156","author":"Michel","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2023.102246_bib50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jaci.2004.11.040","article-title":"Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo","volume":"115","author":"Alexis","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2023.102246_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/ajrccm\/146.2.352","article-title":"Inflammatory response to acute inhalation of endotoxin in asthmatic patients","volume":"146","author":"Michel","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.pupt.2023.102246_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/09680519060120060701","article-title":"Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects","volume":"12","author":"Kitz","year":"2006","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.pupt.2023.102246_bib53","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2125.2012.04287.x","article-title":"Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects","volume":"74","author":"Aul","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102246_bib54","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S1567-5769(02)00147-9","article-title":"Molecular and pharmacological diversity of the kinin B1 receptor","volume":"2","author":"Hess","year":"2002","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.pupt.2023.102246_bib55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00167251","article-title":"The inhibition of alpha 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy","volume":"339","author":"Liebau","year":"1989","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.pupt.2023.102246_bib56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cellsig.2009.03.004","article-title":"Dual positive and negative regulation of GPCR signaling by GTP hydrolysis","volume":"21","author":"Smith","year":"2009","journal-title":"Cell. Signal."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553923000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553923000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:32:02Z","timestamp":1761082322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553923000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":56,"alternative-id":["S1094553923000585"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2023.102246","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2023.102246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102246"}}